Sarpogrelate (Anplag MCI-9042 LS-187118) is a drug which acts as an antagonist at the 5HT2A and 5-HT2B receptors. It blocks serotonin-induced platelet aggregation and has applications in the treatment of many diseases including diabetes mellitus Buerger’s disease Raynaud’s disease coronary artery disease angina pectoris and atherosclerosis.
This page contains content from the copyrighted Wikipedia article "Sarpogrelate"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
